title: Expression of HLA-DR (major histocompatibility complex class II) on neutrophils from patients treated with granulocyte-macrophage colony-stimulating factor for mobilization of stem cells.
authors.forename: S P
authors.initials: SP
authors.lastname: Mudzinski
authors.forename: T P
authors.initials: TP
authors.lastname: Christian
authors.forename: T L
authors.initials: TL
authors.lastname: Guo
authors.forename: E
authors.initials: E
authors.lastname: Cirenza
authors.forename: K R
authors.initials: KR
authors.lastname: Hazlett
authors.forename: E J
authors.initials: EJ
authors.lastname: Gosselin
mesh_terms: D002454:Cell Differentiation; D005786:Gene Expression Regulation / Q000187:drug effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006684:HLA-DR Antigens / Q000096:biosynthesis*; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D009504:Neutrophils / Q000737:chemistry*
chemical_list: D006684:HLA-DR Antigens; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor